人工智能与影像组学在肿瘤影像中的当前应用:叙述性综述,聚焦三大常见癌症
本文为叙述性综述,概述人工智能与影像组学在肿瘤影像中的应用证据与前景,聚焦全球最常见的肺癌、乳腺癌和结直肠癌。文章讨论人工智能与影像组学如何用于癌症的检测、表征及疗效评估,并指出需考虑算法的能力与局限。
要点
- 人工智能与影像组学在肿瘤影像中可用于癌症检测、表征和疗效评估。
- 需明确哪些影像学活动最适合从人工智能与影像组学模型中获益。
- 应用时需同时考虑算法的能力与局限。
核心结论
- 人工智能与影像组学在肿瘤影像中的应用证据与前景被概述,重点涉及肺癌、乳腺癌和结直肠癌的检测、表征及疗效评估。
研究设计与样本
- 叙述性综述,聚焦全球最常见的三种癌症:肺癌、乳腺癌和结直肠癌。
临床应用与阅片要点
- 作者指出,需明确哪些具体影像学活动最适合从人工智能与影像组学模型和方法中获益,并考虑算法的能力与局限。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The use of artificial intelligence (AI) and radiomics in the healthcare setting to advance disease diagnosis and management and facilitate the creation of new therapeutics is gaining popularity. Given the vast amount of data collected during cancer therapy, there is significant concern in leveraging the algorithms and technologies available with the underlying goal of improving oncologic care. Radiologists will attain better precision and effectiveness with the advent of AI technology, making machine-assisted medical services a valuable and important option for future oncologic medical care. As a result, it is critical to figure out which specific radiology activities are best positioned to gain from AI and radiomics models and methods of oncologic imaging, while also considering the algorithms' capabilities and constraints. Our purpose is to overview the current evidence and future prospects of AI and radiomics algorithms used in oncologic imaging efforts with an emphasis on the three most frequent cancers worldwide, i.e., lung cancer, breast cancer and colorectal cancer. We discuss how AI and radiomics could be used to detect and characterize cancers and assess therapy response.
引用
- Vicini, Bortolotto, Rengo, et al. A narrative review on current imaging applications of artificial intelligence and radiomics in oncology: focus on the three most common cancers. Radiol Med. 2022. PMID: 35771379. doi:10.1007/s11547-022-01512-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。